These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 32998391)

  • 1. Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies.
    Wei QY; Xu YM; Lau ATY
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32998391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System.
    Li J; Xie Q; Ma R; Li Y; Yuan J; Ren M; Li H; Wang J; Lu D; Xu Z; Wang J
    Front Med (Lausanne); 2021; 8():750170. PubMed ID: 34901063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design strategy and research progress of multifunctional nanoparticles in lung cancer therapy.
    Min SH; Lei W; Jun CJ; Yan ZS; Guang YX; Tong Z; Yong ZP; Hui LZ; Xing H
    Expert Opin Investig Drugs; 2023; 32(8):723-739. PubMed ID: 37668152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
    Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
    Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amalgamation of Nanotechnology for Delivery of Bioactive Constituents in Solid Tumors.
    Parveen R; Mohapatra S; Ahmad S; Husain SA
    Curr Drug Deliv; 2023; 20(5):457-482. PubMed ID: 35469568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review.
    Ara N; Hafeez A
    AAPS PharmSciTech; 2024 Feb; 25(3):47. PubMed ID: 38424367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.
    Qiu C; Zhang JZ; Wu B; Xu CC; Pang HH; Tu QC; Lu YQ; Guo QY; Xia F; Wang JG
    J Nanobiotechnology; 2023 Nov; 21(1):456. PubMed ID: 38017573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer.
    Mukherjee D; Raikwar S
    AAPS PharmSciTech; 2024 Jul; 25(6):153. PubMed ID: 38961013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
    Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
    Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
    Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
    BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy.
    Nawaz W; Xu S; Li Y; Huang B; Wu X; Wu Z
    Acta Biomater; 2020 Jun; 109():21-36. PubMed ID: 32294554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
    Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
    Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm.
    Beigi A; Naghib SM; Matini A; Tajabadi M; Mozafari MR
    Curr Gene Ther; 2024 May; ():. PubMed ID: 38778601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article.
    Khalifa AM; Elsheikh MA; Khalifa AM; Elnaggar YSR
    J Control Release; 2019 Oct; 311-312():125-137. PubMed ID: 31476342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Up-to-date Review on Protein-based Nanocarriers in the Management of Cancer.
    Almalki WH
    Curr Drug Deliv; 2024; 21(4):509-524. PubMed ID: 37165498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment.
    Song B; Wu S; Li W; Chen D; Hu H
    Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.